About Syndromic sensorineural deafness due to combined oxidative phosphorylation defect
Syndromic sensorineural deafness due to combined oxidative phosphorylation defect is a rare disease catalogued by Orphanet (ORPHA:457223). It is associated with the MRPS7 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Syndromic sensorineural deafness due to combined oxidative phosphorylation defect trials.
Search ClinicalTrials.gov for "Syndromic sensorineural deafness due to combined oxidative phosphorylation defect" or filter by Orphanet code ORPHA:457223 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Syndromic sensorineural deafness due to combined oxidative phosphorylation defect trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Syndromic sensorineural deafness due to combined oxidative phosphorylation defect. Updated daily.